Job opportunities

Announcements from the partners of the GDR

You can find here all announcements given by our partners and sponsors.

DicoveRx Announcement

on 14 May 2013

DiscoveRx offers an industry-leading portfolio of over 600 naturally coupled GPCR cell lines and biochemical assays designed to detect GPCR signaling through arrestin recruitment, second messenger activation (cAMP or Calcium) and receptor internalization. Regardless of the technology platform, DiscoveRx provides the most robust, reliable, high-throughput-friendly, chemiluminescent GPCR assays available. We also offer outsourced screening & profiling services to enable your GPCR projects including pre-defined or custom panels, quantitative dose response curves or library screening.

To learn more about our GPCR product and service menu click here

To request the GDR3545 specific price offer please contact Cédric Audabram: This email address is being protected from spambots. You need JavaScript enabled to view it.

Perkin Elmer Announcement

on 14 May 2013

EnSpire® Multimode Plate Reader with Label-Free Technology

The EnSpire® multimode plate reader is the first detection platform to offer exclusive Corning® Epic® label-free technology and classical labeled detection in a single benchtop instrument. The EnSpire identifies novel molecules and characterizes cellular and biochemical mechanisms of action (MOA) that may go undetected by conventional labeled approaches.

5th HTRF Symposium

on 18 February 2013

HTRF Symposium

Please find all related informations in the attached PDF file.

Download this file (symposium-2013-invitation-web.pdf)HTRF symposium announcement[ ]784 kB

Multispan announcement

on 04 February 2013


Multispan Inc. is a California-based leading provider and partner in GPCR drug discovery. The Company offers a premier human and ortholog GPCR assay platform in calcium, IP-1, cAMP, ERK, radioligand binding, GTPgS and internalization assays for both G-protein and arrestin biased screens with minimal modification to receptors and cells to preserve each receptor’s natural pharmacology. Learn More.